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a b s t r a c t
Plant secondary metabolites are an underutilized pool of bioactive molecules for applications in the food,
pharma and nutritional industries. One such molecule is ﬁsetin, which is present in many fruits and
vegetables and has several potential health beneﬁts, including anti-cancer, anti-viral and anti-aging
activity. Moreover, ﬁsetin has recently been shown to prevent Alzheimer's disease in mice and to prevent
complications associated with diabetes type I. Thus far the biosynthetic pathway of ﬁsetin in plants
remains elusive. Here, we present the heterologous assembly of a novel ﬁsetin pathway in Escherichia
coli. We propose a novel biosynthetic pathway from the amino acid, tyrosine, utilizing nine heterologous
enzymes. The pathway proceeds via the synthesis of two ﬂavanones never produced in microorganisms
before – garbanzol and resokaempferol. We show for the ﬁrst time a functional biosynthetic pathway
and establish E. coli as a microbial platform strain for the production of ﬁsetin and related ﬂavonols.
& 2015 International Metabolic Engineering Society Published by Elsevier Inc. On behalf of International
Metabolic Engineering Society. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Flavonoids are ubiquitous polyphenolic secondary metabolites
produced in many plants. Based on molecular structure, they can
be subdivided into ﬂavonols, ﬂavones, ﬂavonones, isoﬂavones,
catechins, and anthocyanins (Winkel-Shirley, 2001). They are an
important potential source for bioactive molecules. Polyphenols
have been shown to have anti-inﬂammatory, anti-oxidant, anti-
viral, anti-bacterial, anti-cancer, anti-proliferative, and anti-
arteriosclerotic activities (Clere et al., 2011; Gresele et al., 2011;
Middleton et al., 2000; Pan et al., 2010; Ross and Kasum, 2002).
Today ﬂavonoids are mainly obtained by extraction from plants.
Generally, the efﬁcient and cost effective production of ﬂavonoid
compounds continues to be a major challenge. Extraction from
plant material can be unreliable due to unexpected seasonal
changes that may affect plant availability, while the complexity
of the ﬂavonoids themselves limit de novo chemical synthesis of
these compounds (Keasling, 2010; Matkowski, 2008; Paterson and
Anderson, 2005). In addition, production by chemical synthesis or
plant extraction coincides with the use of toxic chemicals and
large amounts of extraction solvents.
The development of microbial cell factories through metabolic
engineering of heterologous biosynthetic pathways into microbes
has emerged as a promising cost effective and more environmen-
tally friendly alternative for large-scale production of ﬂavonoids.
Many genes from plants, bacteria and fungi, have been cloned and
expressed in both Escherichia coli and Saccharomyces cerevisiae for
production of ﬂavonoid compounds, such as naringenin, liquiriti-
genin, pinocembrin and resveratrol (Hwang et al., 2003; Katz et al.,
2011; Leonard and Koffas, 2007; Wu et al., 2013; Yan et al., 2005;
Yan et al., 2007). Furthermore, the microbial production of
ﬂavonoids has emerged as an excellent economical alternative
with a production process characterized by simple, readily avail-
able, inexpensive starting materials as well as the potential for
lower waste emission and energy requirements (Chemler et al.,
2006; Katsuyama et al., 2008; Keasling, 2010).
One of the ﬂavonoids presently receiving increased attention is
ﬁsetin, a bioactive ﬂavonol molecule found in many fruits and
vegetables such as strawberry, apple, persimmon, grape, onion, and
cucumber at concentrations ranging from 2 to 160 μg/g (Khan et al.,
2012). Fisetin has been reported to display anti-aging (Maher,
2009), anti-inﬂammatory (Cho, et al., 2012; Kim et al., 2012), anti-
carcinogenic (Ying et al., 2012) and anti-viral (Kang et al., 2012;
Zandi et al., 2011) properties. In addition, it is claimed to be an
orally active neuroprotective and memory-enhancing molecule
(Maher et al., 2006; Sagara et al., 2004). Recently, ﬁsetin has been
suggested as a new approach for the treatment of Alzheimer's
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disease by Currais et al. (2013) and has been shown to prevent
complications associated with diabetes type I (Maher et al., 2011).
In plants, the aromatic amino acids, L-tyrosine and L-phenyla-
lanine are the precursors of phenolic compounds, such as ﬂavo-
noids and stilbenes. In this study, we focus on L-tyrosine as a
precursor for the production of para (p)-coumaric acid. This can
subsequently be converted into p-coumaroyl-coenzyme A (CoA) by
tyrosine ammonia-lyase (TAL) and 4-coumaroyl-CoA ligase (4CL),
respectively (Fig. 1). The biosynthetic pathway can be directed
either (1) to naringenin by chalcone synthase (CHS) that converts
one molecule of p-coumaroyl-CoA and three molecules of
malonyl-CoA into naringenin chalcone, which is then isomerized
into naringenin by chalcone isomerase (CHI) or (2) to liquiritigenin
by CHS and chalcone reductase (CHR) that converts one molecule
of p-coumaroyl-CoA and three molecules of malonyl-CoA into
isoliquiritigenin. Thus, produced isoliquiritigenin is isomerized
into liquiritigenin in presence of CHI (Fig. 1). In plants, these
ﬂavanone molecules can serve as a common intermediate from
which the biosynthetic pathway can diverge resulting in a panoply
of ﬂavonoids (not shown in Fig. 1). Among the multiple side
branches one can produce ﬁsetin in plants. However, the biosyn-
thetic pathway of ﬁsetin remains unknown. Here, we propose a
novel biosynthetic pathway for the production of ﬁsetin from
L-tyrosine and report the production of ﬁsetin in E. coli.
Based on the molecular structure of ﬁsetin, we hypothesized
that ﬁsetin (as well as garbanzol and resokaempferol) could be
synthesized via a similar pathway to the quercetin biosynthetic
pathway (Fig. 1). Fisetin and quercetin have very similar struc-
tures; in fact, hydroxylation of the 5 position in the A ring of ﬁsetin
yields quercetin. It is known that quercetin is biosynthesized from
the (2S)-ﬂavanone naringenin. Naringenin is converted into dihy-
drokaempferol that is further converted into kaempferol using
ﬂavanone 3-hydroxylase (F3H) and ﬂavonol synthase (FLS),
utilizing O2 and α-ketoglutarate (a-KG). In the ﬁnal step of the
synthetic pathway, quercetin is synthesized from kaempferol. In
plants, this ﬂavonoid hydroxylation step is usually performed by
cytochrome P450 ﬂavonoid monooxygenase (FMO) associated to a
cytochrome P450 reductase (CPR), utilizing O2 and NADPH
(Leonard et al., 2006). We hypothesized that ﬁsetin could be
synthesized from liquiritigenin (Fig. 1). p-Coumaroyl-CoA is con-
verted into isoliquiritigenin by CHS and CHR. CHI converts iso-
liquiritigenin into liquiritigenin, from here the biosynthetic
pathway proceeds to garbanzol, a compound similar in structure
to dihydrokaempferol however lacking the OH group on the A ring
of the ﬂavonone (Fig. 1). Furthermore, we hypothesized that
resokaempferol could be an intermediate in the conversion of
garbanzol to ﬁsetin. Resokaempferol is structurally similar to
kaempferol, which is found in the quercetin biosynthetic pathway,
except for the hydroxyl OH group in the A ring of the ﬂavonone
(Fig. 1). Overall, we suggest that the production of ﬁsetin could
occur via a pathway analogous to the biosynthetic pathway
leading to quercetin production. Thus, three steps catalyzed by
F3H, FLS and FMO/CPR utilizing O2, NADPH and a-KG as cofactors
would convert liquiritigenin to ﬁsetin through the intermediates
garbanzol and resokaempferol (Fig. 1).
2. Materials and methods
2.1. Bacterial strains and plasmids
All strains, vectors, and plasmids used in this study are listed in
Table 1. E. coli DH5α (Invitrogen) was used for plasmid cloning and
propagation, while E. coli BL21(DE3) was used for ﬂavonoid
production. Vectors pACYCDuet-1, pETDuet-1, pCDFDuet-1 and
pRSFDuet-1 (Novagen) were used for cloning and subcloning.
Fig. 1. Plant speciﬁc phenylpropanoid pathway for the synthesis of the ﬂavonoid quercetin (inside dotted line) and proposed phenylpropanoid pathway for the synthesis of
the ﬂavonoid ﬁsetin (outside the dotted line). TAL, tyrosine ammonia-lyase; 4CL, 4-coumaroyl-CoA lyase; CHS, chalcone synthase; CHR, chalcone reductase; CHI, chalcone
isomerase; F3H, ﬂavanone 3-hydroxylase; FLS, ﬂavonol synthase; FMO, ﬂavonoid 30-monooxygenase; CPR and cytochrome P450 reductase.
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Plasmids pCDF-4cl-2Pc (Leonard, et al., 2006), pET-chsPh-chiMs
(Leonard and Koffas, 2007) and pCDF-f3hAt-ﬂs-1At (Malla et al.,
2013) were previously reported.
2.2. Culture media and chemicals
E. coli was grown in 2 yeast extract and tryptone (2YT) broth
or on Luria–Bertania (LB) agar plates supplemented with the appro-
priate amount of antibiotics (100 μg ml1 ampicillin, 25 μg ml1
chloramphenicol, 50 μg ml1 streptomycin/spectinomycin, and
35 μg ml1 kanamycin), when necessary, for the selection or main-
tenance of the plasmids. M9 minimal media with 0.2% (w/v) glucose
were used throughout for ﬂavonoid production. In addition, 2% (w/v)
glycerol was added to the M9 minimal media for the evaluation of
ﬁsetin production from L-tyrosine.
Authentic standards of p-coumaric acid, naringenin, isoliquir-
itigenin, kaempferol, dihydrokaempferol, quercetin, quercetin-
3-O-glucoside and ﬁsetin were purchased from Sigma-Aldrich Co.
(Denmark). Furthermore, authentic standards of naringenin chal-
cone, liquiritigenin and resokaempferol were acquired fromMicro-
CombiChem e.K. (Germany), Tocris Bioscience (United Kingdom)
and Extrasynthese (France), respectively.
2.3. DNA manipulations
Recombinant DNA techniques were performed according to
standard procedures (Sambrook et al., 1989). Restriction enzymes
and T4 DNA ligase were purchased from Thermo scientiﬁc,
Fermentas. Moreover, Gibson assembly master mix were pur-
chased from New England Biolabs and utilized according to the
manufacturer's instructions.
PCR was carried out using phusion polymerase from New
England Biolabs. Oligonucleotide primers were purchased from
Integrated DNA Technologies, BVBA (Belgium). All PCR primers
used in this study are described in Supplementary Table 1.
Codon optimized genes for E. coli were purchased from
GeneArts (Life Technologies™).
2.4. Plasmid construction
For a detailed description of plasmid construction see
Supplementary materials and methods.
2.5. Recombinant protein expression and ﬂavonoid production and
extraction
Unless otherwise stated ﬂavonoid production was carried out
as follows, E. coli BL21(DE3) harboring recombinant plasmids was
precultured in 3 ml of 2YT liquid medium with appropriate
antibiotics and incubated at 37 1C and 250 rpm overnight. The
following day, the preculture was transferred into 2 ml of M9
minimal media (0.2% glucose), with appropriate antibiotics, to a
ﬁnal concentration of OD600 0.05 and cultured at 37 1C and
300 rpm in 24 deep well plates (Enzyscreen B.V., Netherlands)
until OD600 reached 0.6. Then, Isopropyl β-D-1 thiogalactopyr-
anoside (IPTG) was added at a ﬁnal concentration of 1 mM, the
cells grown for 3 h (h) at 30 1C, followed by addition of substrate.
The cultures were cultured using an Innovas 44 orbital shaken
with a 5 cm swing (New Brunswick Scientiﬁc). Depending on the
experiment, either ﬁnal concentrations of 0.5 mM L-tyrosine,
0.075 mM puriﬁed resokaempferol, 0.1 mM liquiritigenin or
0.05 mM liquiritigenin was added and the culture was incubated
Table 1
Bacterial strains and plasmids used in the study.
Strain/plasmid Description Reference
E. coli strains
DH5α General cloning host Invitrogen
BL21(DE3) ompT hsdT hsdS (rB mB) gal (DE3) Novagen
ST1 BL21(DE3) carrying pCDF-talRs-4cl-2Pc and pET-chsPh-chiMs This Study
ST2am BL21(DE3) carrying pCDF-talRs-4cl-2Pc and pET-chsPh-chiMs and pRSF-chrAm This Study
ST2fusion BL21(DE3) carrying pRSF-talRs-4cl-2Pc and pET-chsPhchrAm-chiMs This Study
ST3 BL21(DE3) carrying pCDF-f3hAt-ﬂs-1At Malla, 2013
ST4at BL21(DE3) carrying pACYC f30hAt-cprCr This Study
ST4fxa1 BL21(DE3) carrying pACYC f30hFxa1-cprCr This Study
ST4fxa2 BL21(DE3) carrying pACYC f30hFxa2-cprCr This Study
ST4ph BL21(DE3) carrying pACYC f30hPh-cprCr This Study
ST4mxd BL21(DE3) carrying pACYC f30hMxd-cprCr This Study
ST4cr BL21(DE3) carrying pACYC f3050hCr-cprCr Leonard, 2006
ST5at BL21(DE3) carrying pRSF-talRs-4cl-2Pc and pET-chsPhchrAm-chiMs pCDF-f3hAt-ﬂs-1At and pACYC f30hAt-cprCr This Study
ST5ph BL21(DE3) carrying pRSF-talRs-4cl-2Pc and pET-chsPhchrAm-chiMs pCDF-f3hAt-ﬂs-1At and pACYC f30hPh-cprCr This Study
Plasmid vectors
pETDuet-1 Double T7 promoters; ColE1 ori Ampr Novagen
pCDFDuet-1 Double T7 promoters; CloDF13 ori Smr Novagen
pACYCDuet-1 Double T7 promoters; P15A ori Cmr Novagen
pRSFDuet-1 Double T7 promoters; RSF ori Kmr Novagen
pCDF-4cl-2Pc pCDFDuet-1 carrying 4cl-2 from P. crispum Leonard, 2006
pET-chsPh-chiMs pETDuet-1 carrying chs from P. hybrida and chi from M. sativa Leonard, 2007
pCDF-talRs-4cl-2Pc pCDF-4cl-2Pc carrying tala from R. sphaeroides This Study
pRSF-talRs-4cl-2Pc pRSFDuet-1 carrying tala from R. sphaeroides and 4cl-2 from P. crispum This Study
pET-chsPhchrAm-chiMs pETDuet-1 carrying chs from P. hybrida fused with chra from A. mongholicus and chi from M. sativa This Study
pRSF-chrAm pRSFDuet-1 carrying chra from A. mongholicus This Study
pCDFf3hAt-ﬂs-1At pCDFDuet-1 carrying f3h and ﬂs from A. thaliana Malla, 2013
pACYCf30hAt-cprCr pACYCDuet-1 carrying f30ha from A. thaliana and cpr from C. roseus This Study
pACYCf30hFxa1-cprCr pACYCDuet-1 carrying f30ha from F. x ananassa (1) and cpr from C. roseus This Study
pACYCf30hFxa2-cprCr pACYCDuet-1 carrying f30ha from F. x ananassa (2) and cpr from C. roseus This Study
pACYCf30hMxd-cprCr pACYCDuet-1 carrying f30ha from M. x domestica and cpr from C. roseus This Study
pACYCf3050hCr-cprCr pACYCDuet-1 carrying f30ha from and cpr from C. roseus Leonard, 2006
pACYCf30hPh-cprCr pACYCDuet-1 carrying f30ha from P. hybrida and cpr from C. roseus This Study
a Denotes that genes have been codon optimized for E. coli.
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at 30 1C for 24 h. In the case of ﬁsetin production from reso-
kaempferol, samples were collected at 3 h, 24 h and 48 h, after
addition of resokaempferol. For ﬁsetin production from L-tyrosine
samples were collected at 48 h, after addition of L-tyrosine. For
production of liquiritigenin, collected samples were harvested by
centrifugation at 13,000 rpm (16,200g) for 10 min and the super-
natant was ﬁltered through 0.2 mm ﬁlters and analysed by
high-performance liquid chromatography (HPLC). Garbanzol, reso-
kaempferol and ﬁsetin were extracted directly from 750 μl culture
by adding an equal volume of 99% ethanol (EtOH) followed by
vigorous shaking for one hour. After centrifugation at 13,000 rpm
(16,200g) for 10 min the supernatant was collected and ﬁltered
through 0.2 mm ﬁlters and injected into the HPLC. Experiments
were carried out in triplicates. Sample preparation for HPLC of
garbanzol and resokeampferol production, BL21(DE3) harboring
pCDF-f3hAt-ﬂs-1At was precultured as described above. The fol-
lowing day, the preculture was transferred into 20 ml of M9
minimal medium with antibiotics, to a ﬁnal concentration of
OD600 0.05 and cultured at 37 1C and 300 rpm until OD600 of
0.6 was reached. Then IPTG was added to a ﬁnal concentration of
1 mM and the culture was incubated for 5 h to increase biomass.
The cell pellet was collected by centrifugation and resuspended in
100 ml of M9 minimal media supplemented with 1 mM of IPTG
and 0.1 mM liquiritigenin and cultured at 30 1C and 300 rpm. The
extraction was carried out as previously described by Malla et al.
(2013). Brieﬂy, the culture was extracted with an equal volume of
ethyl acetate and organic layer was collected followed by evapora-
tion of excess solvent to dryness. The remaining products were
dissolved in 99% EtOH for HPLC fractionation, as well as mass
spectrometry (MS) analysis for compound identiﬁcation.
Stability assays of ﬂavonoid compounds are described in
Supplementary materials and methods.
2.6. Flavonoid analysis and quantiﬁcation
The production of ﬂavonoids in recombinant E. coli strains were
analysed and quantiﬁed using a Dionex Ultimate 3000 HPLC with a
Discoverys HS F5-5 column (4.6 by 150 mm; 5.0-mm particle size;
Sigma-Aldrich) connected to a UV detector (277, 290, 333 and
370 nm). Depending on the ﬂavonoid analysed two different
methods were utilized. (A) A ﬂow rate of 1.5 ml/min was used with
a linear gradient of 10 mM ammonium formate pH 3.0 buffer
(mobile phase A) and acetonitrile (mobile phase B) by the following
method: 0–0.5 min (5% B), 0.5–7 min (5 to 60% B), 7–9.5 min (60%
B), 9.5–9.6 min (60 to 5% B), and 9.6–12 min (5% B). Under these
conditions, L-tyrosine was detected at 2.5 min (277 nm), p-coumaric
acid at 5.6 min (333 nm), liquiritigenin at 6.8 min (277 nm), nar-
ingenin at 7.5 min (290 nm) and isoliquiritigenin at 8.0 min
(370 nm) of retention times, respectively. Authentic L-tyrosine,
p-coumaric acid, liquiritigenin, naringenin and isoliquiritigenin
were used as standards. Calibration curves of authentic p-coumaric
acid, naringenin, liquiritigenin and isoliquiritigenin were used for
quantiﬁcation. (B) A ﬂow rate of 1 ml/min was used with a linear
gradient of 10 mM ammonium formate pH 3.0 buffer (mobile phase
A) and acetonitrile (mobile phase B) by the following method:
0–2 min (20% B), 2–20 min (20–45% B), 20–22 min (45–20% B), and
22–24 min (20% B). Under these conditions, dihydrokaempferol was
detected at 10.0 min (333 nm), ﬁsetin at 10.3 min (370 nm), liquir-
itigenin at 12.8 min (277 nm), resokaempferol at 13.3 min (3 7 0),
quercetin at 13.9 min (370 nm), naringenin at 16.7 min (290 nm),
kaempferol at 17.2 min (370 nm) and isoliquiritigenin 19.9 min
(370 nm) of retention times, respectively. Authentic dihydrokaemp-
ferol, ﬁsetin, liquiritigenin, resokaempferol, quercetin, naringenin,
kaempferol and isoliquiritigeninwere used as standards. Calibration
curves of authentic resokaempferol and authentic ﬁsetin were used
for quantiﬁcation. Putative garbanzol and resokaempferol peaks
were puriﬁed using a semi prep a Dionex Ultimate 3000 HPLC
equipped with a fraction collector, using a Discoverys HS F5-5
column (4.6 by 150 mm; 5.0-mm particle size; Sigma-Aldrich)
connected to a UV detector (277, 290, 333 and 370 nm). A ﬂow
rate of 1 ml/min was used with a linear gradient of 10 mM
ammonium formate pH 3.0 buffer (mobile phase A) and acetonitrile
(mobile phase B) by the following method: 0–3 min (20% B),
3–21 min (20–45% B), 21 to 23 min (45%B), 23 to 25 min (45–20%
B) and 25–33 min (20% B).
2.7. Elucidation of garbanzol, resokaempferol and ﬁsetin
The previously isolated compounds (garbanzol and resokaemp-
ferol) were dried at room temperature under reduced pressure
using a Centrifugal Vacuum Concentrator (Savant SpeedVacs
Concentrator, Thermoﬁsher Scientiﬁc, Waltham Ma) followed by
reconstitution using a 0.1% solution of formic acid in LC-MS grade
acetonitrile (250 ml). The samples (produced ﬁsetin, garbanzol and
resokaempferol) were then analysed by directed infusion on a
VelosPro linear ion trap mass spectrometer (Thermoﬁsher Scien-
tiﬁc, Waltham Ma), using the built-in syringe pump, (set at a ﬂow
rate of 10 ml min1). Both positive and negative ion electrospray
modes were used, with data being collected in centroid mode. MS1
and MS2 spectra for each sample were acquired; the MS2
were acquired at collision energies of 30 V and 40 V in both
ionization modes.
3. Results
3.1. Production of liquiritigenin from L-tyrosine
To verify the upstream part of the proposed pathway, we initially
obtained pCDF-4cl-2Pc – the pCDFDuet-1 plasmid carrying the native
4cl-2 gene from Petroselinum crispum as well as pET-chsPh-chiMs –
the pETDuet-1 plasmid carrying the native chs from P. hybrida and
the native chi gene from Medicago Sativa (Leonard et al., 2006;
Leonard and Koffas, 2007). TAL from R. sphaeroides (TALrs), codon
optimized for E. coli, was cloned into the pCDF-4cl-2Pc recombinant
plasmid, upstream of the 4cl-2 gene, under the T7 promoter in MCS1
(4CLpc is located downstream of the T7 promoter in MCS2). Subse-
quently, the talrs4clpc DNA fragment was subcloned into the
pRSFDuet-1 vector. pRSF-talRs-4cl-2Pc and pET-chsPh-chiMs were
then transformed into BL21(DE3) creating E. coli strain ST1 synthe-
sizing naringenin (Table 2). Production of liquiritigenin requires the
expression of CHR, the branch point enzyme, in addition to CHS.
Therefore, pRSF-chrAmwas constructed, using a codon optimized chr
gene from A. mongholicus (CHRam) followed by transformation into
E. coli BL21(DE3) strain ST1 creating strain ST2am. CHR from A.
mongholicus has recently been characterized (Xu et al., 2012).
Hypothesizing that CHS co-act with CHR in catalyzing the substrate
p-coumaroyl-CoA into isoliquiritigenin, the two genes were fused
together, only separated by a linker consisting of glycine and serine
creating pET-chsPhchrAm-chiMs. Together with pRSF-talRs-4cl-2Pc
this fusion plasmid was transformed into E. coli BL21(DE3), resulting
in strain ST2fusion. As expected, when supplemented with 0.5 mM L-
tyrosine, strains ST1, ST2am and ST2fusion all produced naringenin,
while only ST2am and ST2fusion produced isoliquiritigenin and
liquiritigenin (Table 2). Interestingly, when CHS and CHR were fused
together the production of liquiritigenin was increased by almost
four-fold (Table 2). An E. coli strain carrying both of the empty vectors
pRSFDuet-1 and pETDuet-1 did not produce naringenin, liquiriti-
genin or isoliquiritigenin.
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3.2. Production of garbanzol and resokaempferol
In order to conﬁrm the assumption that F3H and FLS are active
on liquiritigenin through the intermediates garbanzol and reso-
kaempferol, native F3H and FLS from Arabidopsis thaliana were
utilized by transforming plasmid pCDF-f3hAt-ﬂs-1At into BL21
(DE3) creating E. coli strain ST3. F3H and FLS have previously been
shown to convert naringenin into dihydrokaempferol and kaemp-
ferol, respectively by introducing a hydroxyl group in the C-3
position of the C ring followed by the formation of a double bond
between the C-2 and C-3 carbons in the C ring of the chalcone
structure (Fig. 1, synthesis of ﬂavonol from dihydroﬂavonol) (Malla
et al., 2012; Malla et al., 2013; Leonard et al., 2006). F3H and FLS
were selected based on the high structural similarities between
dihydrokaempferol and garbanzol as well as kaempferol and
resokaempferol (Fig. 1).
ST3 was cultivated and production of dihydrokaempferol and
kaempferol was detected after 24 h upon supplying the cells with
naringenin (Fig. 2A, B).
The ﬂavonoids were identiﬁed by HPLC comparing the reten-
tion times and UV absorbance spectra of the extracted ﬂavonoids
with authentic compounds. F3H and FLS from A. thaliana showed
activity towards naringenin, producing dihydrokaempferol and
kaempferol. No dihydrokaempferol or kaempferol were detected
in a control experiment using BL21(DE3) carrying pCDFDuet-1
(Fig. 2C).
Subsequently, E. coli strain ST3 was evaluated for production of
garbanzol and resokaempferol after 24 h upon supplementing the
cells with liquiritigenin (Fig. 2D). The identiﬁcation of garbanzol is
putative as no authentic garbanzol is commercially available or
could be obtained to be used as a standard compound. Liquiriti-
genin was detected after a retention time of 12.8 min and
isoliquiritigenin after a retention time of 19.9 min. Resokaempferol
was detected at a retention time of 13.3, conﬁrmed by UV spectra
and retention time comparison with an authentic resokaempferol
standard. An unknown peak in the chromatogram at 8.0 min was
observed (Figure D). Since naringenin and dihydrokaempferol
displayed similar UV spectra's, it was hypothesized that the
unidentiﬁed peak could be garbanzol (Fig. 2) based on the high
similarities observed for the UV spectra between liquiritigenin and
putative garbanzol (Fig. 2E). No peaks similar to putative garbanzol
and resokaempferol were detected in a control experiment using
BL21(DE3) carrying pCDFDuet-1 (Fig. 2E). Isoliquiritigenin was
detected in the control experiment, as liquiritigenin can be non-
enzymatically isomerized into isoliquiritigenin at both high and
neutral pH conditions, and at temperatures above 4 1C (Simmler et
al., 2013). The UV-spectra of all the compounds are shown in Fig. 2.
3.3. Elucidation of garbanzol and resokaempferol
To ﬁrmly assign the identity of the ﬂavonoids produced in the
engineered E. coli strain, ST3 was cultured in M9 minimal media
(0.2% glucose) for 48 h upon supplementation with liquiritigenin.
Flavonoid compounds were extracted with an equal volume of
ethyl acetate and injected into an HPLC-fraction collector and the
peaks tentatively assigned as resokaempferol and garbanzol pur-
iﬁed. After puriﬁcation the putative garbanzol and resokaempferol
were injected into a high resolution LC-MS (Thermo Orbitrap
Fusion™) for further elucidation and compound identiﬁcation with
msn (Supplementary Fig. 1A and B). The spectra for the compound
tentatively assigned as garbanzol showed an ion with m/z
273.07565 which corresponds to within 0.4 ppm of the mass
of an ion with the ionic formula of C15H13O5 in positive ion mode
and an ion withm/z 271.06055 corresponds to within 2.4 ppm of
the mass of an ion with the ionic formula of C15H11O5 in negative
ion mode, indicative of a compound with a molecular formula of
C15H12O5 (Supplementary Fig. 1A). This ﬁnding is consistent with
the isolated molecule being garbanzol having a molecular formula
of C15H12O5. Furthermore, infusion of the puriﬁed resokaempferol
gave a spectra (Supplementary Fig. 1B), which showed an ion with
m/z 271.06005 corresponding to within 0.2 ppm of an ion with
the ionic formula of C15 H11O5 in positive ion mode and an ion with
m/z 269.04521 corresponding to within 1.3 ppm of an ion with
the ionic formula of C15H9O5 in negative ion mode. Infusion of the
resokaempferol standard (Supplementary Fig. 1C) gave ions with
m/z 271.06010 corresponding to within 0.0 ppm of an ion with the
ionic formula of C15 H11O5 in positive ion mode and m/z 269.04521
corresponding to within 1.4 ppm of an ion with the ionic
formula of C15 H9O5 in negative ion mode. Examination of the
MS2 spectra revealed that the fragmentation patterns are consis-
tent with each other.
3.4. Cytochrome P450 screening and ﬁsetin production
In order to elucidate the ﬁnal step in the putative ﬁsetin
biosynthetic pathway, from resokaempferol to ﬁsetin, a set of
different cytochrome P450 monooxygenases (F30H, ﬂavonoid 30
monooxygenase) were evaluated. The genes were selected based
on (i) novelty (ii) likelihood of participation in ﬁsetin production in
strawberry as well as (iii) previous characterizations (Thill et al.,
2013; Leonard et al., 2006). To examine the functional expression of
the genes, a previously described method was utilized, with minor
modiﬁcations (Leonard et al., 2006, Hotze et al., 1995). Initially, all of
the genes were codon optimized for E. coli, truncated, fused with
truncated cytochrome P450 reductase (CPR, codon optimized) from
C. roseus, cloned into pACYCDuet-1 and transformed into BL21
(DE3), respectively. Thus, the following strains were created: ST4at
carrying F30H from A. thaliana; ST4fxa1 and ST4fxa2 carrying F30Hs
from two subspecies of F. x ananassa, ST4mxd carrying F30H fromM.
x domestica and ST4ph carrying F30H from P. hybrida. Furthermore, a
previously described strain, that had been shown to convert
kaempferol into quercetin, ST4cr carrying F3050H from C. roseus
(Leonard et al., 2006) was reconstructed in a similar manner as
described above. However, unlike in the previous study, the gene
was codon optimized for E. coli. In order to evaluate the six strains,
0.05 mM resokaempferol was supplied, and bioconversion products
were analysed after 3 h, 18 h and 40 h of cultivation, by HPLC,
comparing the retention times and UV absorbance spectra of
ﬂavonoids with authentic ﬁsetin and authentic resokaempferol
(Fig. 3). Three hours after addition of resokaempferol, ﬁve strains:
ST4cr, ST4at, ST4fxa2, ST4mxd and ST4ph produced ﬁsetin in
detectable amounts. The highest amount was observed from ST4at
at 1.2 mg l1 of ﬁsetin, followed by ST4ph producing 0.25 mg l1,
ST4fxa2 producing 0.15 mg l1 and ST4cr and ST4mxd both produ-
cing 0.04 mg l1 of ﬁsetin (Fig. 3). ST4fxa1 and BL21(DE3) contain-
ing an empty pACYCDuet-1 vector did not produce any ﬁsetin after
3 h. At 18 h after addition of resokaempferol, ﬁsetin was detected in
samples from ST4at at 2.1 mg l1, ST4ph at 0.92 mg l1, ST4fxa2 at
0.1 mg l1 and ST4cr at 0.6 mg l1. For ST4fxa1, ST4mxd and BL21
(DE3) containing an empty pACYCDuet-1 vector, ﬁsetin was not
detected. After 40 h, ﬁsetin was detected in amounts varying from
Table 2
The production of p-coumaric acid (PCA), naringenin (NRN), liquiritigenin (LIQ) and
isoliquiritigenin (ILQ) using recombinant E. coli strains ST2am, ST2fusion and ST1.
Production (mg l1)
PCA NRN LIQ ILQ
ST2am 17.670.25 0.2270.03 0.5170.08 0.1370.02
ST2fusion 13.072.31 0.1170.01 1.8470.23 0.4170.07
ST1 10.270.39 0.8170.08 070.0 070.0
S.G. Stahlhut et al. / Metabolic Engineering 31 (2015) 84–9388
Fig. 2. Typical HPLC proﬁle of (A) naringenin supplemented E. coli strain ST3 at wavelength 290 nm (B) naringenin supplemented E. coli strain ST3 at wavelength 370 nm
(C) naringenin supplemented E. coli strain carrying pCDFDuet-1 at wavelength 290 nm (D) liquiritigenin supplemented E. coli strain ST3 at wavelength 333 nm
(E) liquiritigenin supplemented E. coli strain carrying pCDFDuet-1 at wavelength 333 nm. (F) UV spectra of HPLC analysed compounds. NRN denotes naringenin,
DHK – dihydrokaempferol, KMF – kaempferol, ILQ – isoliquiritigenin, LIQ – liquiritigenin, GAR – garbanzol and RSK – resokaempferol. Experiments were carried out in
triplicates.
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0.06 to 0.15 mg l1 in all of the strains expressing P450 monoox-
ygenase. For BL21(DE3) containing an empty pACYCDuet-1 vector,
ﬁsetin was not detected after 40 h. The decrease of the ﬁsetin
concentration over time suggests that ﬁsetin is unstable in M9
minimal media (see below).
Overall, the P450s evaluated here from various origins, all
showed conversion of resokaempferol to ﬁsetin. Subsequently, in
order to verify that we indeed produce ﬁsetin, a collected sample
from ST4cr was evaluated further. The HPLC detected peak which
eluted at the same retention time as the ﬁsetin standard was
analysed on a linear ion trap and therefore the masses are
reported at unit mass (Supplementary Fig. 2A). The observed ions
287 in positive mode and 285 are consistent with those observed
in the ﬁsetin standard. The spectra for the infusion of the ﬁsetin
standard (Supplementary Fig. 2B) gave an ion with m/z 287.05487
which corresponds to within 0.5 ppm of ion with the ionic
formula of C15H11O6 in positive ion mode and an ion with m/z
285.03997 corresponds to within 1.7 ppm of ion with the ionic
formula of C15H9O6 in positive ion mode, indicative of compound
with a molecular formula of C15H10O6. The MS2 spectra show that
the fragmentation patterns in both positive and negative ioniza-
tion modes are consistent with both spectra being from ﬁsetin.
3.5. Fisetin production from L-tyrosine
To investigate the complete biosynthetic pathway from
L-tyrosine to ﬁsetin, pRSF-talRs-4cl-2Pc pET-chsPhchrAm-chiMs
and pCDF-f3hAt-ﬂs-1At was transformed into ST4at, and ST4ph,
respectively, creating ST5at and ST5ph. The two constructed
strains were cultivated (0.5 mM of L-tyrosine was supplied), and
bioconversion products were analysed after 48 h of cultivation by
HPLC analysis, comparing the retention times and UV absorbance
spectra of ﬂavonoids with authentic ﬁsetin as well as all of the
intermediates in the pathway (Table 3).
E. coli strain ST5at was cultured in M9 minimal media contain-
ing 0.2% (w/v) glucose. However, only p-coumaric acid and
garbanzol could be detected (data not shown). Subsequently, in
order to increase the biomass E. coli strains ST5at and ST5ph were
cultured in M9 minimal media containing 0.2% (w/v) glucose and
2% (w/v) glycerol. Remarkably, in addition to p-coumaric acid and
garbanzol both ST5at and ST5ph produced ﬁsetin (Table 3). Thus,
after 48 h of cultivation ST5at produced 10.0 mg l1 of p-coumaric
acid, a detectable amount of garbanzol (no standard could be
obtained for quantiﬁcation) and 0.25 mg l1 of ﬁsetin while ST5ph
produced 12.1 mg l1 of p-coumaric acid, a detectable amount of
garbanzol and 0.3 mg l1 of ﬁsetin. The produced ﬁsetin was
successfully veriﬁed by high resolution LC-MS (Thermo Orbitrap
Fusion™) (data not shown). No other intermediates of the pathway
were detected. No compounds were detected in control samples
containing E. coli strain BL21(DE3) carrying all four empty vectors,
pCDFDuet-1, pRSFDuet-1, pETDuet-1 and pACYCDuet-1. Thus, the
production of ﬁsetin in bacteria is reported for the ﬁrst time.
3.6. Stability of ﬂavonoids
The instability of ﬁsetin in M9 media prompted the investiga-
tion of the other compounds in the quercetin and ﬁsetin pathways
for stability issues. Therefore, L-tyrosine, p-coumaric acid, isoli-
quiritigenin, naringenin chalcone, liquiritigenin, naringenin, gar-
banzol, dihydrokaempferol, resokaempferol, kaempferol, quercetin
and ﬁsetin were evaluated for stability in M9 media over a period
of 48 h without presence of E. coli in the media.
Non-enzymatically isomerization of isoliquiritigenin and liquir-
itigenin as well as of naringenin chalcone and naringenin was
herein conﬁrmed (data not shown) (Simmler et al., 2013). Dihy-
drokaempferol was not degraded after 24 h, however after 48 h
dihydrokaempferol was not detected and naringenin appeared,
suggesting a non-enzymatic dehydration of dihydrokaempferol to
naringenin in M9 media (data not shown).
Intriguingly, apart from dihydrokaempferol, of the compounds
evaluated here, only ﬁsetin and quercetin showed instability in M9
media, suggesting that the ﬂavonol molecule becomes instable
with the addition of a second –OH group to the C-ring (of the basic
structure) (Fig. 4A). To investigate if the stability of the ﬂavonol
molecule could be increased, quercetin-3-O-glucoside was
Fig. 3. Resokaempferol supplemented E. coli strains carrying truncated codon
optimized CPR from C. roseus and codon optimized F30H from A. thaliana (ST4at),
F. x ananassa 1 (ST4fxa1), F. x ananassa 2 (ST4fxa2), P. hybrida (ST4ph) and M. X
domestica (ST4mxd) as well as F3050H from C. roseus (ST4cr). Concentration (mg
l1) of ﬁsetin in samples after 3 h (white bars), 18 h (gray bars) and 40 h (black
bars) after addition of resokaempferol are displayed. Experiments were carried out
in triplicates. The mean values of three experiments are shown along with SEM.
Table 3
Production of ﬁsetin (FIS) and detected intermediates, p-coumaric acid (PCA) and
garbanzol (GAR) from L-tyrosine using recombinant E. coli strains ST5at and ST5ph.
Production (mg l1)
ST5at ST5ph
PCA 10.071.0 12.174.29
GAR Detected Detected
FIS 0.2570.04 0.370.12
Fig. 4. (A) Stability of ﬁsetin, quercetin and quercetin-3-O-glucoside in M9 minimal
media at 30 1C at time 0 h, 24 h and 48 h. Experiments were carried out in
triplicates. The mean values of three experiments are shown along with SEM.
(B) quercetin-3-O-glucoside.
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evaluated in the stability assay (Fig. 4A&B). Indeed, addition of a
sugar molecule to quercetin (glycosylation) rendered the molecule
stable (Fig. 4A).
4. Discussion
There is an increasing demand for a stable/sustainable supply
of high quality and novel bioactive ingredients. Flavonoids repre-
sent a promising group of molecules that may ﬁnd application as
pharmaceutical drugs or nutraceutical ingredients. Here, a syn-
thetic ﬁsetin pathway comprised of genes from various hetero-
logous sources (mostly plants) was assembled and the functional
expression in E. coli veriﬁed.
In recent years, introduction and expression of natural plant
pathways in non-native hosts such as E. coli and other micro-
organisms have proven to be a robust and sustainable alternative
(Keasling, 2010). However, pathway elucidation and subsequently
the validation thereof play an important role for the successful
production of ﬂavonoids in the selected heterologous host organ-
ism. Despite ﬁsetin being found in various plants, its natural
biosynthetic pathway has yet to be fully elucidated. Since ﬁsetin
is a valuable plant natural product from both a human health and
economic perspective, the characterization of ﬁsetin's biosynthetic
pathway is pivotal in order to generate new approaches for its
production.
At the onset of this work, we hypothesized a novel biosynthetic
pathway for the production of ﬁsetin from L-tyrosine, inspired by
the biosynthetic pathway of quercetin.
The upstream part of the proposed pathway was evaluated by
expressing TAL, 4CL, together with CHS, CHI and CHR in E. coli.
Interestingly, accumulation of p-coumaric acid was detected inde-
pendently of the expression of the CHR enzyme, in all three strains
investigated here. This suggests that the 4CL from P. crispum is a
limiting factor in the pathway. Furthermore, in the presence of p-
coumaric acid, E. coli has been shown to up-regulate an efﬂux
pump (Licandro-Seraut et al., 2013). This would suggest some
removal of energy from the heterologous pathway, in order for the
cell metabolism to deal with the stress from p-coumaric acid. The
accumulation of p-coumaric acid may be due to a limited supply of
acetyl-CoA needed for the formation of malonyl-CoA; thus, limit-
ing 4CL activity. This view is in agreement with previous studies
showing that supplied p-coumaric acid was only efﬁciently con-
verted into naringenin after optimization of the malonyl-CoA
supply (Xu et al., 2011; Kim et al., 2013).
A key step in the biosynthetic pathway of ﬁsetin from
L-tyrosine is the coordinated activities of CHR and CHS. These
enzymes catalyze the conversion of p-coumaroyl-CoA into isoli-
quiritigenin and thus directing the metabolic ﬂux in the biosyn-
thetic pathway away from naringenin chalcone and subsequently
naringenin, dihydrokaempferol, kaempferol and quercetin
(Ballance and Dixon, 1995).
Two different approaches were evaluated to test the capability
of CHR on directing the ﬂux in the pathway towards isoliquiriti-
genin and subsequently liquiritigenin, garbanzol, resokaempferol
and ﬁsetin. (1) CHR from A. mongholicus was cloned downstream
of its own T7 promoter on a high copy number plasmid and
(2) CHR from A. mongholicus was fused together with CHS from P.
hybrida on a medium copy number plasmid. The latter was carried
out based on the idea that CHS and CHR perform protein-protein
interactions (Winkel-Shirley, 1999).
Interestingly, the ﬂux towards liquiritigenin was increased
compared to naringenin when CHR was fused together with
CHS, with concentration of liquiritigenin 18-fold higher than
naringenin. In contrast, when CHR was cloned alone, the amount
of liquiritigenin was only two-fold higher than naringenin. Thus
more ﬂux was directed towards liquiritigenin, when CHR was
fused together with CHS. Previously, by utilization of an in vitro
enzymatic assay it was shown that puriﬁed CHR and CHS added in
a 2:1 ratio, had a production ratio of 1:1 of liquiritigenin and
naringenin (Welle and Schroder, 1992). This would suggest an
overexpression of CHR compared to CHS could increase the ﬂux
towards liquiritigenin. However, we show that co-expression of
CHS and CHR 1:1 (rather than separately) results in increased
in vivo ﬂux towards liquiritigenin in E. coli. In the subsequent part
of the proposed pathway from liquiritigenin to resokaempferol
through garbanzol, the enzymes F3H and FLS were evaluated for
their ability to convert these compounds.
Indeed, the enzymes were shown to convert liquiritigenin into
garbanzol and resokaempferol. Thus, FLS and F3H from A. thaliana
are not only capable of catalyzing naringenin into kaempferol via
dihydrokaempferol but also capable of catalyzing the conversion
of liquiritigenin into garbanzol and subsequently resokaempferol
(Fig. 1). This would suggest that these two enzymes from A.
thaliana are promiscuous towards ﬂavanones and that they have
the ability to convert various ﬂavanones into ﬂavonols.
The major bottleneck in the generation of hydroxylated ﬂavo-
noids in E. coli, such as the ﬂavonols ﬁsetin and quercetin, is the
functional expression of the membrane associated plant P450
hydroxylases ﬂavonoid 30-hydroxylase (F30H) and ﬂavonoid
3050-hydroxylase (F3050H), due to the insolubility of these enzymes
(Oeda et al., 1985), limitations of heme biosynthesis (Gallagher et
al., 1992; Sinha and Ferguson, 1998), or lack of CPR function
(Nelson et al., 1993; Porter et al., 1987). In order to achieve the
biochemical synthesis of the hydroxylated ﬂavonol ﬁsetin from
resokaempferol, we progressed with the functional expression of
different ﬂavonoid 30-hydroxylase (F30H) of different origins and
reconstructed a previously reported ﬂavonoid 30-50–hydroxylase
(F3050H) from C. roseus, since the latter was shown to convert
kaempferol into quercetin (Leonard et al., 2006). Furthermore, to
ensure that only the hydroxylation of the 30 position of the C ring
of resokaempferol was targeted thereby enabling the conversion
to ﬁsetin, we primarly focused on F30H enzymes. F3050H were
excluded since they have previously been shown to perform both
30 and 30,50 –hydroxylation reactions (Kaltenbach et al., 1999).
Using F30H from A. thaliana, F. x ananassa, M. x domestica and P.
hybrida we were able to convert resokaempferol into ﬁsetin.
Interestingly, even with protein sequences differing substantially
from each other (similarity ranging from 48% to 97%), all P450's
monooxygenase's investigated, demonstrated bioconversion abil-
ities in converting resokaempferol into ﬁsetin in the E. coli host.
The production of ﬁsetin was considerably higher when F30H
from A. thaliana and P. hybrida were used to catalyze the step from
resokaempferol to ﬁsetin, compared to the remaining F30H pro-
teins evaluated here. Whether or not, this is due to a higher
speciﬁcity, afﬁnity, gene expression or overall function in E. coli
remains to be investigated.
E. coli was chosen as a production host due to fast growth
combined with easy handling and a vast set of molecular tools
available. However, for the expression of plant cytochrome P450's
the yeast Saccharomyces cerevisiae is usually the preferred host
based on a superior protein expression machinery compared to E.
coli (Zhou et al., 2015). Hence, S. cerevisiae is another attractive
host for production of ﬁsetin and related polyphenols.
The observed instability of ﬁsetin and quercetin in the bacterial
media can be potentially solved by glycosylation of the com-
pounds, which in turn would stabilize them. Hence, a promising
metabolic engineering strategy is the additional expression of a
ﬁsetin speciﬁc O-glycosyltransferase to the assembled pathway to
produce ﬁsetin glucoside and thereby to avoid ﬁsetin degradation.
Finally, in order to evaluate the complete hypothetical pathway
in a single cell of E. coli, the enzymes TAL, 4CL, CHSCHR, CHI, F3H,
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FLS and F30HCPR were expressed in E. coli and L-tyrosine used as a
substrate for synthesis of ﬁsetin. We show here for the ﬁrst time
an E. coli cell factory capable of converting the aromatic amino acid
into ﬁsetin. Except for p-coumaric acid and garbanzol no other
intermediate could be detected, suggesting a full conversion of all
intermediates and/or a low ﬂux through the pathway.
This study elucidates and demonstrates a functional expression
of a novel biosynthetic pathway towards the biosynthesis of the
high-value plant compound ﬁsetin in E. coli. Demonstrating the
functionality of the different reported enzymatic steps to convert
(I) L-tyrosine into liquiritigenin, (II) liquiritigenin into resokaemp-
ferol, (III) resokaempferol into ﬁsetin and (IV) L- tyrosine into
ﬁsetin.
Finally, in order to further improve the created ﬁsetin produ-
cing bacterial cell factory, described here, further pathway opti-
mization could be conducted. This could be carried out using
biosensors like the one recently published by Siedler et al. (2014),
as well as cofactor engineering and increasing the supply of
important precursors including malonyl-CoA.
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